Dr. Byrne Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has extensive experience in delivering regional cancer therapies, such as heated intraperitoneal chemotherapy (HIPEC) and surgical management of metastatic disease in the liver and peritoneum. He is a specialist in performing surgery for cancers of the stomach, liver, pancreas, small intestine, colon and soft tissue sarcoma, and utilizes minimally invasive and robotic surgical techniques when appropriate.

Dr. Lee received his medical degree from New York Medical College, completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at City of Hope National Cancer Center. He was the leader of the Peritoneal Surface Malignancy Program at City of Hope before joining Stanford in 2019 where he leads the Regional Cancer Therapies program.

His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary and peritoneal surface malignancies, and is a member of a national consensus group conducting collaborative research and developing clinical trials for HIPEC surgeries.